Patients who carried the functional CD44 variant rs187115 G might possess greater chemoresistance to advanced- to late-stage oral cancer than WT carriers do, and CD44 rs187115 might act as a marker to predict poor prognoses in OSCC patients. Here, CD44 is linked to lip and oral cavity carcinoma.